Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study

Autor: Mourits, Maarten P, van Kempen-Harteveld, M Loes, García, M Begoña García, Koppeschaar, Hans PF, Tick, Lidwine, Terwee, Caroline B

Publikováno v: In The Lancet 2000 355(9214):1505-1509

The influence of serotonergic neurotransmission on pituitary hormone release in obese and non-obese females

Autor: Pijl, Hanno, Koppeschaar, Hans PF, Willekens, Frans LA, Frölich, Marijke, Meinders, A Edo

Publikováno v: European Journal of Endocrinology; April 1993, Vol. 128 Issue: 4 p319-324, 6p

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients

Autor: Sjöström, Lars, Rissanen, Aila, Andersen, Teis, Boldrin, Mark, Golay, Alain, Koppeschaar, Hans PF, Krempf, Michel

Publikováno v: The Lancet; 1998, Vol. 352 Issue: 9123 p167-172, 6p

Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial.

Autor: Tuiten A; 1 Emotional Brain BV, Almere, The Netherlands., Michiels F; 2 Chemistry and Life Sciences, V.O. Patients & Trademarks, Amsterdam, The Netherlands., Böcker KB; 3 Alan Turing Institute Almere, Almere, The Netherlands., Höhle D; 3 Alan Turing Institute Almere, Almere, The Netherlands., van Honk J; 4 Department of Experimental Psychology, Utrecht University, Utrecht, The Netherlands.; 5 Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.; 6 Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa., de Lange RP; 3 Alan Turing Institute Almere, Almere, The Netherlands., van Rooij K; 1 Emotional Brain BV, Almere, The Netherlands.; 7 Utrecht Institute for Pharmaceutical Sciences and Rudolf Magnus Institute of Neuroscience, Utrecht University, Utrecht, The Netherlands., Kessels R; 1 Emotional Brain BV, Almere, The Netherlands., Bloemers J; 1 Emotional Brain BV, Almere, The Netherlands.; 7 Utrecht Institute for Pharmaceutical Sciences and Rudolf Magnus Institute of Neuroscience, Utrecht University, Utrecht, The Netherlands., Gerritsen J; 1 Emotional Brain BV, Almere, The Netherlands.; 7 Utrecht Institute for Pharmaceutical Sciences and Rudolf Magnus Institute of Neuroscience, Utrecht University, Utrecht, The Netherlands., Janssen P; 8 Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; 9 Department of Central Hospital Pharmacy, Viecuri Hospital, Venlo, The Netherlands., de Leede L; 10 Exelion Bio-Pharmaceutical Consultancy B.V., Waddinxveen, The Netherlands., Meyer JJ; 3 Alan Turing Institute Almere, Almere, The Netherlands.; 11 Department of Information and Computing Sciences, Utrecht University, Utrecht, The Netherlands., Everaerd W; 12 Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands., Frijlink HW; 13 Research Group of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherland., Koppeschaar HP; 1 Emotional Brain BV, Almere, The Netherlands., Olivier B; 7 Utrecht Institute for Pharmaceutical Sciences and Rudolf Magnus Institute of Neuroscience, Utrecht University, Utrecht, The Netherlands.; 14 Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.; 15 Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands., Pfaus JG; 16 Department of Psychology, Centre for Studies in Behavioral Neurobiology, Concordia University, Montreal, QC, Canada.

Publikováno v: Women's health (London, England) [Womens Health (Lond)] 2018 Jan-Dec; Vol. 14, pp. 1745506518788970.